DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

Drug Metabolism and Disposition Fast Forward
First published on July 27, 2004; DOI: 10.1124/dmd.104.000372

0090-9556/04/3210-1139-1145$20.00
DMD 32:1139-1145, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.104.000372v1
32/10/1139    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gerk, P. M.
Right arrow Articles by Vore, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gerk, P. M.
Right arrow Articles by Vore, M.

ESTRADIOL 3-GLUCURONIDE IS TRANSPORTED BY THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 BUT DOES NOT ACTIVATE THE ALLOSTERIC SITE BOUND BY ESTRADIOL 17-GLUCURONIDE

Phillip M. Gerk, Wei Li, and Mary Vore

Graduate Center for Toxicology, University of Kentucky, Lexington, Kentucky

ß-Estradiol 17-(ß-D-glucuronide) (E217G) is a well known cholestatic agent and substrate of multidrug resistance-associated protein 2 (Mrp2), whereas ß-estradiol 3-(ß-D-glucuronide) (E23G) is a noncholestatic regioisomer of E217G with unknown transport properties. The purpose of this study was to compare and contrast the Mrp2-mediated transport of E217G and E23G. The full coding region of rat Mrp2 was cloned into the baculovirus genome, the recombinant baculovirus used to infect Sf9 cells, and ATP-dependent transport of 3H-E23G and 3H-E217G in Sf9 cell membranes was characterized. Mrp2 transported E23G into an osmotically sensitive space, requiring ATP, with S50 = 55.7 µM, Vmax = 326 pmol·mg-1·min-1, and a Hill coefficient of 0.88. ATP-dependent Mrp2-mediated E217G transport was markedly stimulated at high E217G concentrations, consistent with positive cooperativity (Hill coefficient 1.5). E217G (5-125 µM) increased S50 but not Vmax for E23G transport, consistent with competitive inhibition. E23G (0.4-400 µM) completely, potently (IC50 = 14.2 µM), and competitively inhibited E217G transport, but E217G (0.01-250 µM) inhibited only 53% of E23G transport (IC50 = 33.4 µM). Estriol 16{alpha}-(ß-D-glucuronide) potently and completely inhibited transport of E23G (IC50 = 2.23 µM), as did ß-estradiol 3-sulfate 17-(ß-D-glucuronide) (5-50 µM). In summary, E217G binds not only to an Mrp2 transport site, but also to an allosteric site that activates Mrp2 with positive cooperativity, thus activating its own transport and potentially that of other Mrp2 substrates, such as E23G. The noncholestatic E23G is an Mrp2 substrate and competes with E217G for transport, but does not activate the allosteric site.

Address correspondence to: Dr. Mary Vore, University of Kentucky, Graduate Center for Toxicology, Room 306 HSRB, Lexington, KY 40536-0305. E-mail: maryv{at}uky.edu




This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
K. Heredi-Szabo, H. Glavinas, E. Kis, D. Mehn, G. Bathori, Z. Veres, L. Kobori, O. von Richter, K. Jemnitz, and P. Krajcsi
Multidrug Resistance Protein 2-Mediated Estradiol-17{beta}-D-glucuronide Transport Potentiation: In Vitro-in Vivo Correlation and Species Specificity
Drug Metab. Dispos., April 1, 2009; 37(4): 794 - 801.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
J. S. Lagas, C. M. M. van der Kruijssen, K. van de Wetering, J. H. Beijnen, and A. H. Schinkel
Transport of Diclofenac by Breast Cancer Resistance Protein (ABCG2) and Stimulation of Multidrug Resistance Protein 2 (ABCC2)-Mediated Drug Transport by Diclofenac and Benzbromarone
Drug Metab. Dispos., January 1, 2009; 37(1): 129 - 136.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
C. Zimmermann, K. van de Wetering, E. van de Steeg, E. Wagenaar, C. Vens, and A. H. Schinkel
Species-Dependent Transport and Modulation Properties of Human and Mouse Multidrug Resistance Protein 2 (MRP2/Mrp2, ABCC2/Abcc2)
Drug Metab. Dispos., April 1, 2008; 36(4): 631 - 640.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. M. Gerk, W. Li, V. Megaraj, and M. Vore
Human Multidrug Resistance Protein 2 Transports the Therapeutic Bile Salt Tauroursodeoxycholate
J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 893 - 899.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
M. Ninomiya, K. Ito, R. Hiramatsu, and T. Horie
Functional Analysis of Mouse and Monkey Multidrug Resistance-Associated Protein 2 (Mrp2)
Drug Metab. Dispos., December 1, 2006; 34(12): 2056 - 2063.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
P. Jungsuwadee, M. P. Cole, R. Sultana, G. Joshi, J. Tangpong, D. A. Butterfield, D. K. St. Clair, and M. Vore
Increase in Mrp1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C57BL/6 mice.
Mol. Cancer Ther., November 1, 2006; 5(11): 2851 - 2860.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
H. E. Meyer zu Schwabedissen, G. Jedlitschky, M. Gratz, S. Haenisch, K. Linnemann, C. Fusch, I. Cascorbi, and H. K. Kroemer
VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
Drug Metab. Dispos., July 1, 2005; 33(7): 896 - 904.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.